INTEGER HOLDINGS CORPORATION Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value
INTEGER HOLDINGS CORPORATION (ITGR) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value of $9.18 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-23.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue · last filed 2026-02-23
- INTEGER HOLDINGS CORPORATION share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for fiscal 2025 was $9.18M, a 357.55% increase from fiscal 2024.
- INTEGER HOLDINGS CORPORATION share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for fiscal 2024 was $2.01M, a 45.31% decline from fiscal 2023.
- INTEGER HOLDINGS CORPORATION share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for fiscal 2023 was $3.67M, a 891.89% increase from fiscal 2022.
- INTEGER HOLDINGS CORPORATION share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for fiscal 2022 was $370.00K, a 84.39% decline from fiscal 2021.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value 12 month |
|---|---|
| 2025-12-31 | $9.18M 10-K · filed 2026-02-23 |
| 2024-12-31 | $2.01M 10-K · filed 2026-02-23 |
| 2023-12-31 | $3.67M 10-K · filed 2026-02-23 |
| 2022-12-31 | $370.00K 10-K · filed 2025-02-20 |
| 2021-12-31 | $2.37M 10-K · filed 2024-02-20 |
| 2020-12-31 | $4.77M 10-K · filed 2023-02-21 |
| 2019-12-31 | $8.00M 10-K · filed 2022-02-22 |
| 2018-12-28 | $17.72M 10-K · filed 2021-02-18 |
| 2017-12-29 | $13.93M 10-K · filed 2020-02-20 |
| 2016-12-30 | $690.00K 10-K · filed 2019-02-22 |
| 2016-01-01 | $8.23M 10-K · filed 2018-02-22 |
| 2015-01-02 | $8.00M 10-K · filed 2017-02-28 |
| 2014-01-03 | $6.81M 10-K · filed 2016-03-01 |
| 2012-12-28 | $148.00K 10-K · filed 2015-03-03 |
| 2011-12-30 | $501.00K 10-K · filed 2014-03-04 |
| 2010-12-31 | $112.00K 10-K · filed 2013-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| LivaNova PLC (LIVN) | $4.158B | 24.01 | |
| TransMedics Group, Inc. (TMDX) | United States | $2.911B | 15.17 |
| Axogen, Inc. (AXGN) | United States | $2.329B | -73.83 |
| BIOLIFE SOLUTIONS INC (BLFS) | United States | $1.887B | 23.80 |
| CONMED Corp (CNMD) | United States | $1.353B | 26.72 |
| Ceribell, Inc. (CBLL) | United States | $0.916B | -11.27 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |